Last reviewed · How we verify

NCT03113708: LBWH

The Effect of Heparinization Due to LBW

Status unknown Phase 4 Last updated 14 April 2017
What this trial tests

Phase 4 trial testing Heparin Sodium in Heparin in 50 participants. Status unknown.

Timeline
30 April 2017
Primary endpoint
20 May 2017
20 June 2017

Quick facts

Lead sponsorAdiyaman University Research Hospital
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment50
Start date30 April 2017
Primary completion20 May 2017
Estimated completion20 June 2017

Drugs / interventions tested

Conditions studied

Sponsor

Adiyaman University Research Hospital

Who can join

Adults 18 to 65, any sex, with Heparin or Heparin Overdose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High dose heparin regimens are required in cardiac surgery under cardiopulmonary bypass (CPB) and this may increase postoperative bleeding. The aim of this study is to evaluate the effect of heparin dose calculated according to lean body weight on intraoperative and postoperative bleeding.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heparin

Currently open trials in the same condition.

Other Adiyaman University Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03113708.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing